Nationales Centrum für Tumorerkrankungen (NCT)

Research facility

Location: Heidelberg, Dresden, Berlin, Essen, Köln, Würzburg, Erlangen, Regensburg, Augsburg, Tübingen, Stuttgart, Ulm, Germany (DE)

ISNI: 0000000088550365

ROR: https://ror.org/01txwsw02

Show on Map:

Publications

(70)

Research Grants

(1)

Health related Quality of Life over time in German sarcoma patients. An analysis of associated factors - results of the PROSa study (2023) Eichler M, Hentschel L, Singer S, Hornemann B, Richter S, Hofbauer C, Hohenberger P, et al. Journal article The German Network for Personalized Medicine to enhance patient care and translational research (2023) Illert AL, Stenzinger A, Bitzer M, Horak P, Gaidzik VI, Möller Y, Beha J, et al. Journal article Lactate dehydrogenases promote glioblastoma growth and invasion via a metabolic symbiosis (2022) Guyon J, Fernandez-Moncada I, Larrieu CM, Bouchez CL, Pagano Zottola AC, Galvis J, Chouleur T, et al. Journal article A randomized phase II trial of ipilimumab and nivolumab versus standard of care in previously untreated and advanced non-clear cell renal cell carcinoma (SUNNIFORECAST) (2022) Ahrens M, Escudier B, Haanen J, Gross-Goupil M, Boleti E, Gravis G, Grimm MO, et al. Conference contribution The quality of national skin cancer screening from the perspective of general practitioners: A questionnaire-based comparison between Saxony and Bavaria (SaBaScreen) (2022) Strasser C, Reinhardt L, Steeb T, Wessely A, Schelling J, Petzold A, Heppt M, et al. Conference contribution The Therapeutic Role of Plastic and Reconstructive Surgery in the Interdisciplinary Treatment of Soft-Tissue Sarcomas in Germany-Cross-Sectional Results of a Prospective Nationwide Observational Study (PROSa) (2022) Thomas B, Bigdeli AK, Nolte S, Gazyakan E, Harhaus L, Bischel O, Lehner B, et al. Journal article Model soups improve performance of dermoscopic skin cancer classifiers (2022) Maron RC, Hekler A, Haggenmüller S, von Kalle C, Utikal JS, Müller V, Gaiser M, et al. Journal article Severe Dysbiosis and Specific Haemophilus and Neisseria Signatures as Hallmarks of the Oropharyngeal Microbiome in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients (2022) De Castilhos J, Zamir E, Hippchen T, Rohrbach R, Schmidt S, Hengler S, Schumacher H, et al. Journal article Tailored Immunotherapy Approach With Nivolumab in Advanced Transitional Cell Carcinoma (2022) Grimm MO, Schmitz-Dräger BJ, Zimmermann U, Grün CB, Baretton GB, Schmitz M, Foller S, et al. Journal article A Novel 2-Metagene Signature to Identify High-Risk HNSCC Patients amongst Those Who Are Clinically at Intermediate Risk and Are Treated with PORT (2022) Patil S, Linge A, Hiepe H, Grosser M, Lohaus F, Gudziol V, Kemper M, et al. Journal article

‹ 1 2 3 4 5 ... 7 ›